熱點掃描 | 醫藥股下挫，復星醫藥大跌超9%
uSMART盈立智投 07-06 11:03
uSMART盈立智投7月6日消息，港股三大指數繼續走弱，恆指跌0.42%，報28020.60，成交額559.27億，國企指數跌0.31%，恆生科技指數跌1.03%，港股通淨流出1.29億。
體育用品板塊拉昇，截止10:53，特步漲近3%，361度漲超1%，李寧漲超1%，安踏則小幅下跌0.5%左右。
港口航運股走高，截止10:53，中遠海控漲超6%，海豐國際、太平洋航運、東方海外國際漲幅不足1%。招商證券近日發佈研報稱，基於較高的行業景氣度，該行預計中遠海控21 年運量同比增加9.5%。從季度來看，Q2/Q3 或將爲盈利高點，預計即期運價在Q4 逐步回落。
恆生科技指數繼續下行，截止10:53，阿裏健康跌近6%，平安好醫生、明源雲跌超3%，金山軟件、中芯國際、閱文集團、舜宇跌超2%，快手、美團跌超1%，b站、阿裏跌幅不足1%，其中江蘇國資聯手阿裏、小米等組團戰投蘇寧易購；騰訊轉漲，先漲近1%，小米、京東、百度均微弱上漲，海爾智家漲近2%。
物管股走弱，截止10:53，世茂服務、恆大物業、綠城管理控股、綠城服務均跌超3%，保利物業、華潤萬象生活、融創服務跌超2%，碧桂園服務跌超1%。
醫藥股下挫，截止10:53，復星醫藥、康龍化成、信達生物均大跌超9%，康哲藥業跌超8%，四環醫藥跌超7%，開拓藥業、先聲藥業均跌超6%，和黃醫藥、石藥集團跌超5%。
個股方面，截止10:53，海底撈反彈超6%，機構稱其仍爲火鍋行業領導者且估值吸引；醫思健康漲超4%破頂，富瑞上調目標價3.2倍，另有多家大行唱好；錦欣生殖跌超11%，母公司以每股18.22–18.72港元配售4200萬股股票；
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
